Adding Amplia Therapeutics‘ experimental drug narmafotinib to standard chemotherapy led to complete responses — meaning no detectable cancer on imaging scans for at least…
News
Myosin Therapeutics has been awarded $2 million in funding to support a Phase 1/2 clinical trial testing its lead experimental cancer therapy, MT-125, in…
Overt Bio said it established a clinical advisory board to support the development of OVT-101, its lead investigational CAR T-cell therapy for ovarian cancer,…
Tempus AI, a technology company focused on advancing precision medicine using artificial intelligence (AI), has announced a strategic collaboration with the advocacy organization…
Caris Life Sciences has launched a new diagnostic tool that aims to help guide treatment decisions for people with pancreatic ductal adenocarcinoma (PDAC), the…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AMXT 1501 to treat malignant…
Researchers have developed a new cell therapy that aims to treat endometrial cancer by targeting cancer cells while also depleting immune cells that help protect…
Add-on treatment with mezigdomide significantly delayed cancer progression among people with hard-to-treat myeloma in a Phase 3 clinical trial, according to interim data announced…
Sellas Life Sciences is seeking people with newly diagnosed acute myeloid leukemia (AML) for a clinical trial testing its experimental anticancer therapy SLS009…
People with advanced pancreatic cancer who followed a ketogenic diet program administered by Virta Health while receiving chemotherapy tended to live longer than…
